RE: Consultation document20 Jun 2021 11:16
You’re welcome all. It’s refreshing to read as it aligns with PresAl’s sentiment that there is substantial demand. Given the document mentions they will need to continue with imports to supplement the U.K. manufacturing, it’s clear that the govt are interested in taking all that the U.K. can offer. The downsides are the usual ones, timescales and trust. I agree oxygen, there is and has been no urgency, they’ve been happy to use lockdowns rather than take advantage of testing as a solution, so timescales are lengthy. As for trust, we’ve got to trust that they will properly validate our product and give it the full recognition it deserves. As they’ve said, once the market opens up, in a free market quality alongside price will be very important. If I was making procurement decisions I’d want to buy the very best and nothing can better finding 100% of the infectious. It would also protect margins.
Who knows what conversations have taken place, perhaps the govt have said that they’re happy with Innova until the free market arrives which has spurred PresAl in to looking to Europe in the meanwhile. All the above certainly fits with everything he’s said about the U.K. market and being able to sell everything we make. It’s just taking a long time. *insert Guinness tagline*